Natural History Study of Parathyroid Disorders
NCT04969926 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2026-05-12
Summary
Background:
Parathyroid disorders are very common in the general population and include disorders of parathyroid excess, deficiency, or defects in parathyroid hormone (PTH) signaling. PTH, the main secretory product of parathyroid glands is responsible for regulation of calcium-phosphate homeostasis.
Objective:
i) To investigate the cause of parathyroid disorders
ii) To describe evolution, natural history, and longitudinal trends of parathyroid and related disorders seen in syndromic presentations like multiple endocrine neoplasia, hyperparathyroidism-jaw tumor syndrome
Eligibility:
People ages 6 months older who have, are at risk of having, or are related to a person with a parathyroid or related disorder.
Design:
Participants will be screened with a review of their medical records.
Participants will be seen, tested, and treated by doctors based on their condition. Their visits may be in person or via telehealth.
Participants will complete questionnaires. They will answer questions about their physical, mental, and social health.
Participants may give samples such as saliva, blood, urine, or stool.
Participants may give cheek cell samples. They will do this using a cheek swab or by spitting into a cup.
Adult participants may give a skin biopsy. For this, a small bit of skin is removed with a punch tool.
Participants may have medical photos taken.
If participants have surgery during the course of their regular care either at the NIH
or at a different hospital or doctor s office, researchers will ask for some of the leftover
tissue.
Participants will be in the study as long as they are being seen by their doctor.
Conditions
- Parathyroid Cancer
- Primary Hyperparathyroidism
- Pseudohypoparathyroidism
- Inheritable Bone Diseases
- Multiple Endocrine Neoplasia, Type 1
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
lead NIH
Principal Investigators
-
Smita Jha, M.D. · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eligibility
- Min Age
- 6 Months
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-30
- Primary Completion
- 2031-01-22
- Completion
- 2031-01-22
Countries
- United States
Study Locations
More Related Trials
-
Hypoparathyroidism in Denmark
NCT01498341 ·Status: COMPLETED
-
Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism
NCT03052075 ·Status: UNKNOWN
-
Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders
NCT00403598 ·Status: UNKNOWN
-
Burden of Illness in Hypoparathyroidism
NCT03437174 ·Status: COMPLETED
-
Treatment With PTH After Sternotomy in Cardiac Surgery Patients
NCT01466829 ·Status: COMPLETED ·Phase: PHASE3
-
Circulating miRNA in Primary Hyperparathyroidism
NCT03931109 ·Status: COMPLETED
-
Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism
NCT02005250 ·Status: COMPLETED
-
The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism
NCT02216721 ·Status: COMPLETED
-
Studying Phosphorus Metabolism
NCT00066183 ·Status: COMPLETED
-
Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study
NCT00430417 ·Status: COMPLETED
-
The Effects of Bovine Colostrum in Bone Metabolism in Humans
NCT04040010 ·Status: COMPLETED ·Phase: NA
-
Role of T-cells in Post-Menopausal Osteoporosis
NCT00787904 ·Status: COMPLETED
-
Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism
NCT06419270 ·Status: COMPLETED
-
Multicenter Registry Study of Chronic Hypoparathyroidism in Chinese Adults
NCT05214274 ·Status: COMPLETED
-
PATHophysiology of OSteoporosis: Role of Hidden Cortisol Excess and Its Predictors in Bone Fragility
NCT06324084 ·Status: RECRUITING
-
Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia
NCT00694525 ·Status: UNKNOWN
-
Magnesium Supplementation to Prevent Bone Loss
NCT00346658 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Low Bone Mass in Premenopausal or Perimenopausal Women
NCT00005101 ·Status: COMPLETED
-
The Relationship Between Ca Intake , Blood Level of Ca, PTH, TSH, Vitamin D, and Urine Ca, P and Cardiac Calcium Scoring
NCT02035033 ·Status: UNKNOWN
-
MACS and Healthy Volunteers Bone Study
NCT04343560 ·Status: COMPLETED
-
Osteogenic Profiling of Normal Calvarial Bone
NCT02933359 ·Status: COMPLETED
-
Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density
NCT01250314 ·Status: COMPLETED ·Phase: NA
-
Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism
NCT02524041 ·Status: COMPLETED ·Phase: NA
-
The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin
NCT00665613 ·Status: COMPLETED
-
The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton
NCT02357277 ·Status: WITHDRAWN ·Phase: PHASE4